Navigation Links
Onda Marks 250th AIMS Shipment
Date:6/21/2013

SUNNYVALE, Calif., June 21, 2013 /PRNewswire/ -- Onda Corporation, the global leader in ultrasound measurements, announced today that it shipped its 250th AIMS shipment.  The latest generation hydrophone scanning system, the AIMS III with Soniq v.5.1 software, automatically maps the acoustic fields of ultrasonic devices.  The hallmark unit shipped to DJO Global, a world leader in providing intelligent medical devices and services.  The AIMS III will be used to test and control the acoustic properties of physiotherapy ultrasonic devices.

Mr. Tony Allen, Senior Vice President of Operations at DJO Global, comments, "We continue to invest in our measurement capability to ensure our ultrasound transducers are consistent in their performance and safety.  The measurement requirements for physiotherapy devices are complex, and we consider the partnership we have with Onda as a critical piece to this success."

"As a metrology company, Onda is committed to delivering the highest quality instruments to the ultrasound community," says Dr. Sam Howard, CTO and an expert in the regulatory community.  He comments further, "Much of our success is attributed to the continuous support from our customers.  Understanding their measurement needs is what shapes our products, such as the AIMS III, into what they are today."

About Onda

Onda Corporation provides ultrasound measurement instrumentation and services. Decades of engineering have culminated into a suite of measurement instruments used to acoustically characterize and control a variety of complex medical and industrial devices.  Beyond its product line, Onda also offers a broad range of services that include the testing, design, development, and manufacturing of devices. 

For more information, visit: http://www.ond
'/>"/>

SOURCE Onda Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Hobart Group Holdings Marks 10th Anniversary With Multiple Milestones
2. Cellular Biomedicine Group Marks the Launch of China Clinical Trial for TC-DC Therapy for Hepatocellular Carcinoma
3. Managed Health Care Associates, Inc. (MHA) Marks Tenth Anniversary of Hosting Annual Business Summit for Long Term Care, Home Infusion, Home Medical Equipment and Specialty Pharmacies
4. Study Delivers Investment Benchmarks across Key New Product Launch Activities in Pharmaceutical Sector
5. Hologic, Inc. Marks Breast Cancer Awareness Month by Ringing the Opening Bell at NASDAQ and Taking 3D Mammography on the Road
6. Quest Diagnostics Marks Ninth Year on Dow Jones Sustainability Index
7. Emmaus Medical Marks Progression of Phase 3 Sickle Cell Disease Clinical Trial During Sickle Cell Awareness Month
8. Staffing and Performance Benchmarks for Regulatory Function Highlight New Medical Device Study
9. Pharmacists United for Truth and Transparency Marks One Year Anniversary of Fighting Abuses by Pharmacy Benefits Managers
10. SynCardias Record-Setting Q2 Marks 5th Consecutive Profitable Quarter
11. Cardiac Science Earns Top Marks for Cardiac Stress Test, Telemetry Monitor Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 17, 2014 Research and Markets ... Cancer Market 2014-2018" report to their offering. ... growth of cancerous cells in the breast tissue. It ... cancer is rare. Histologically, breast cancer can be classified ... undifferentiated carcinoma. Ductal carcinoma is the form of breast ...
(Date:9/16/2014)... , 17. September 2014 ... ), hat heute die Markteinführung des ... Probenverarbeitung, in Europa bekannt gegeben. Der ... Universalplattform zur Vereinfachung der präanalytischen Probenverarbeitung. ... und fehlerbehaftete Arbeitsschritte bei der manuellen ...
(Date:9/16/2014)... 2014 3SBio Inc., ("3SBio") a leading ... focusing on researching, developing, manufacturing and marketing ... into an exclusive license agreement with JenKem Technology ... marketing in Mainland China of PEG-irinotecan, a long-acting ... is over-expressed in many solid tumors, including colorectal, ...
Breaking Medicine Technology:Global Breast Cancer Market 2014-2018: Key Vendors are Astrazeneca, Eli Lilly and Company and F. Hoffmann-La Roche, Novartis and Sanofi-Aventis 2Global Breast Cancer Market 2014-2018: Key Vendors are Astrazeneca, Eli Lilly and Company and F. Hoffmann-La Roche, Novartis and Sanofi-Aventis 3Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 2Hologic stellt in Europa den Tomcat vor, ein neues Gerät zur präanalytischen Probenverarbeitung 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 23SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 33SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 43SBio Inc. obtains exclusive licenses to develop and market JenKem's PEG-Irinotecan in China 5
... N.J., Oct. 27 Watson Pharmaceuticals, Inc. (NYSE: ... Laboratories, Inc., filed a new drug application under Section ... (FFDCA) with the U.S. Food and Drug Administration (FDA) ... and 40 mg tablets.  Watson,s rosuvastatin zinc tablets are ...
... Oct. 27 Intrinsic Bioprobes today announced that ... issued US Patent 7,816,095 covering novel blood protein ... first of a series of patent applications that ... clinical utility. "The biomarkers were discovered ...
Cached Medicine Technology:Watson Confirms Crestor® Patent Challenge 2Intrinsic Bioprobes Announces Issuance of US Patent for Novel Biomarkers and Assays for Myocardial Infarction 2
(Date:9/17/2014)... Acceleratio Ltd., an innovative software development ... of Server Monitoring Toolkit , a web ... It brings real-time server monitoring via a live ... enhanced features that significantly improve troubleshooting and detection ... agentless data collection, a user-friendly interface, and many ...
(Date:9/17/2014)... 17, 2014 Lintelus, Inc., a ... it has released Lintelus Meeting Version 3.1, designed ... corporate events. The newest release includes features to ... management capabilities and allow a more personalized event ... Lintelus Meeting 3.1 offers product advancements including real-time ...
(Date:9/17/2014)... HERNDON, VIRGINIA (PRWEB) September 17, 2014 ... top rhinoplasty specialist surgeons, has been recognized as a recipient ... is reserved for only the best of the best as ... by specialty. , Dr. Naderi, who is affectionately known by ... of only a handful of true rhinoplasty specialist ...
(Date:9/17/2014)... Promising new research published in the ... on the potential ability of ketones to support brain ... The study shows that brain hypometabolism associated ... impaired glucose uptake and/or utilization, and results suggest that ... The study, by the Research Center on Aging and ...
(Date:9/17/2014)... TENN. September 16, 2014) A study led ... found the chemotherapy dose threshold below which male ... sperm production. The study appears in September 17 ... , By clarifying which patients are at highest ... expect the findings to eventually increase use of ...
Breaking Medicine News(10 mins):Health News:New Server Monitoring Toolkit v6 Brings Real-Time Windows Server Monitoring and New Server Reports 2Health News:New Server Monitoring Toolkit v6 Brings Real-Time Windows Server Monitoring and New Server Reports 3Health News:Lintelus Energizes Audiences with the Latest Version Of its Multi-Screen Interactive Software 2Health News:Vitals Honors Dr. Shervin Naderi With Top 10 Doctor Award 2Health News:Vitals Honors Dr. Shervin Naderi With Top 10 Doctor Award 3Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 2Health News:Journal of Alzheimer's Disease Publishes New Study Suggesting Ketones have Potential to Compensate for Brain Energy Deficit 3Health News:Improved risk identification will aid fertility preservation in young male cancer patients 2Health News:Improved risk identification will aid fertility preservation in young male cancer patients 3
... , , WEDNESDAY, Nov. 14 (HealthDay News) -- During a ... drugs to be sold by pharmacists without a prescription, ... for and against the proposal by representatives of various ... day,s end, the FDA officials said they weren,t ready ...
... a,statement from Jeff Levi, Executive Director of Trust ... (TFAH) urges Congress to override the,President,s veto of ... Agencies Appropriations bill., The Labor/HHS bill provides ... states, territories, localities and hospitals to prepare for,public ...
... Kalamazoo, Mich.-based,Stryker Corporation and its former outpatient ... pay the United States $16.6,million to settle ... and other federal health care programs, the ... allegations that Physiotherapy, which is based,in Memphis, ...
... announced today,that the U.S. Food and Drug ... beta) for the treatment of anemia,associated with ... patients,on dialysis and patients not on dialysis. ... (CKD). MIRCERA is the only FDA-approved,erythropoiesis-stimulating agent ...
... Conference Call Scheduled for November 20, NAPA, Calif., ... specialty life sciences company engaged in the,study of senescense, ... skincare,and dermatological therapeutics today announced financial results for the,quarter ... quarter 2007 were $469,000 compared to,$2,027,000 for the same ...
... Natural Nutrition,(OTC Bulletin Board: NNTN) ( http://www.naturalnutritioninc.com ) ... of 10-QSB. Chris Mathers, CFO of,Natural Nutrition said, ... filing for Natural Nutrition will not be filed ... record revenue of $12.644,million and record EBITDA of ...
Cached Medicine News:Health News:FDA Hears Pros, Cons of Pharmacist-to-Patient Drug Sales 2Health News:FDA Hears Pros, Cons of Pharmacist-to-Patient Drug Sales 3Health News:FDA Hears Pros, Cons of Pharmacist-to-Patient Drug Sales 4Health News:Stryker Corp. & Physiotherapy Associates to Pay U.S. $16.6 Million for Alleged False Claims to Federal Health Care Programs 2Health News:FDA Approves MIRCERA(R): First Renal Anemia Treatment with Monthly Maintenance Dosing 2Health News:FDA Approves MIRCERA(R): First Renal Anemia Treatment with Monthly Maintenance Dosing 3Health News:Senetek PLC Reports Third Quarter 2007 Financial Results 2Health News:Senetek PLC Reports Third Quarter 2007 Financial Results 3Health News:Natural Nutrition to Report Record Revenue and EBITDA in Late Filing of 10-QSB 2
... developed the world's first 8-channel ... completely AC powered in 1951. ... a number of standard setting ... systems, such as a Windows ...
... you're getting an ambulatory and a clinical EEG ... Mobee O2 can be used for ambulatory EEG ... or in-lab sleep studies. And both feature 32 ... placement. The Mobee O2 includes the additional enhancement ...
... The VISULAS 690s is the ... the instrument of choice for ... clinical trials, Carl Zeiss has ... in laser manufacturing to create ...
... Humphrey Lens Analyzers Model 350 and ... most comprehensive lensometry for your practice. ... Analyzer (LA) gives fast and accurate ... lenses, prism lenses, contact lenses, polycarbonate ...
Medicine Products: